How to Buy Prothena Public Co Stock
Prothena Corp Public Ltd Co
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States.
Prothena Public Co stock last closed at $36.08, down 4.55% from the previous day, and has decreased 39.02% in one year. It has underperformed other stocks in the Biotechnology industry by 0.14 percentage points. Prothena Public Co stock is currently +26.55% from its 52-week low of $28.51, and -54.7% from its 52-week high of $79.65.
At the moment, there are 53.67M PRTA shares outstanding. The market capitalization of PRTA is $1.94B. In the last 24 hours, 560,708 PRTA shares were traded.
How to Buy Prothena Public Co Stock
Not sure how to invest in Prothena Public Co stock? Here's how.
- Figure out where to buy Prothena Public Co stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Prothena Public Co stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Pick your payment method and add your details.
- Analyze Prothena Public Co stock: The Prothena Public Co ticker symbol is PRTA. Is Prothena Public Co stock a good investment? Should you buy shares of PRTA? How do PRTA's underlying business fundamentals look? Do top analysts think Prothena Public Co is a good buy? Why has PRTA's stock price moved recently? (Hint: Our stock research website can help you evaluate if PRTA is a good stock to buy).
- Execute your PRTA buy order: Decide if you will purchase PRTA shares at the current market price or use a limit order to buy PRTA stock at a specific price.
- Keep tabs on your PRTA investment: Create a watchlist to watch your position in Prothena Public Co shares.
Step 1: Figure out where to buy Prothena Public Co stock
You will need a brokerage account to access the NASDAQ market and buy PRTA shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PRTA stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start your new brokerage account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've created your account on the best stock broker app, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of depositing money into your new investment account.
Step 4: Analyze Prothena Public Co stock
After you have chosen the best place to buy Prothena Public Co stock, it's absolutely critical to evaluate their stock before you buy, so you actually understand the risk and upside.
Prothena Public Co stock data
PRTA Fundamentals
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on PRTA's stock page.
Is PRTA stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge PRTA's intrinsic value.
Using relative valuations measures:
- PRTA may be undervalued based on its P/B ratio of 3.14x, relative to Biotechnology industry P/B ratio of 5.42x
You can access additional valuation analysis on PRTA's stock here.
Is PRTA a healthy company?
Passed Financial Due Diligence Checks:
- PRTA has a low debt to equity ratio of 0.21.
- PRTA has $672.25M in cash and short term investments. This is sufficient to cover its annual cash burn of $89.26M.
- Total PRTA debt is lower than 5 years ago, relative to shareholder equity.
- PRTA has cash burn of 89256000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the PRTA balance sheet.
- There are more short-term assets than long-term liabilities on the PRTA balance sheet.
Failed Financial Due Diligence Checks:
- PRTA profit margin has gone up by 29.84 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Prothena Public Co stock, according to Wall Street analysts?
Out of 3 Wall Street analysts who monitor PRTA, the consensus analyst rating on PRTA is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Prothena Public Co stock forecast page.
PRTA Trading Indicators
Is PRTA Making Money?
Last year, PRTA revenue was $140.98M. During the last five year, PRTA's revenue has gone up by 169.59% per year. This was faster than the Biotechnology industry average of 37.17%.
Dig into PRTA's earnings and revenue performance here.
Who is buying/selling PRTA?
In the past 12 months, executives and large shareholders at PRTA have bought as many shares as they have sold.
Karin L. Walker, Chief Accounting Officer of PRTA, was the latest PRTA insider to sell. They sold $170,000.00 worth of PRTA shares on Nov 30, 2023.
Research more about who owns PRTA stock here.
Can I rely on PRTA as an income stream?
No, Prothena Public Co doesn't provide an income stream by paying out dividends.
PRTA Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your PRTA buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular price, use a limit order.
Hit the Open Trade button and your broker will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Step 6: Keep tabs on your PRTA investment
Now that you own some PRTA stock, you'll want to stay up-to-date on your company.
Create a watchlist to get notified of the latest news about your PRTA stock.
PRTA Feed
How to Buy Stock in Prothena Public Co
To summarize, here are the 6 steps you need to take to buy Prothena Public Co stock right now:
- Figure out where to buy Prothena Public Co stock
- Sign up for your brokerage account
- Deposit funds into your investment account
- Analyze Prothena Public Co stock
- Execute your PRTA buy order
- Keep tabs on your PRTA investment
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest news on your investment in Prothena Public Co, create a watchlist on WallStreetZen today.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.